La cadena de opciones muestra datos clave de las opciones de acciones de Bluejay Diagnostics a varios precios de ejercicio y fechas de vencimiento. Los operadores utilizan esta información para analizar posibles operaciones y evaluar el sentimiento del mercado para Bluejay Diagnostics..

Bluejay Diagnostics (NASDAQ:BJDX) Bolsa, Cadena de Opciones

Bluejay Diagnostics

Bluejay Diagnostics Inc is a medical diagnostics company. It is developing rapid tests using whole blood using its Symphony technology platform to improve patient outcomes in critical care settings. The company's first product, the Symphony IL-6 test, is for the monitoring of disease progression in critical care settings and is a clinically established inflammatory biomarker for the assessment of the severity of infection and inflammation across many disease indications, including sepsis.

Bluejay Diagnostics Inc

Egg prices in the U.S. have risen 60% over the past year, due in large part to the bird flu ravaging commercial flocks. Here's a look at why experts see the<a href="https://www.benzinga.com/general/biotech/25/01/43117087/bird-flu-update-first-commercial-case-in-georgia-moderna-receives-590-million-to-develop-vaccine"> prices continuing to climb.</a> 
The Details: The average price for a dozen large, grade-A eggs rose 60% over the past year, reaching $4.15 in December, according <a href="https://data.bls.gov/timeseries/APU0000708111">to data</a> from the Bureau of Labor Statistics. The USDA predicts egg prices <a href="https://www.ers.usda.gov/data-products/food-price-outlook/summary-findings#:~:text=In%202025,%20prices%20for%20all,of%20-2.7%20to%205.5%20percent.%5C">will </a>rise another 45% in 2025 due to a strain of bird flu known as H5N1 that killed 13.2 million commercial egg-laying hens in December.
Read Next: <a href="https://www.benzinga.com/general/travel/25/01/43343648/all-60-passengers-4-crew-members-onboard-american-airlines-jet-feared-dead-after-midair-collision-official-says">64 Killed In American Airlines Midair Collision Near D.C., Worst US Air Disaster Since 2001&nbsp;</a>
On top of the record-high prices, consumers are also facing egg shortages and purchase limits at major retailers like Costco Wholesale Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COST#NASDAQ">COST</a>) and Albertsons Companies, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ACI#NYSE">ACI</a>). 
Data from the U.S. Department of Agriculture shows that a record number of more than 20 million egg-laying chickens died in the last quarter due to bird flu.&nbsp;
In an attempt to contain the virus, farmers are compensated for chickens and eggs that are destroyed through a USDA program which said it had paid out $1.25 billion to farmers since the outbreak started in 2022, according to a CBS News <a href="https://www.cbsnews.com/news/egg-industry-chicken-deaths-bird-flu/">report</a>.&nbsp;
In fact, egg producers are reporting record profits during the latest bird flu outbreak. Cal-Maine Foods Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CALM#NYSE">CALM</a>), the nation's largest egg producer, reported<a href="https://www.benzinga.com/news/earnings/25/01/42862269/cal-maine-foods-stock-climbs-after-strong-q2-results-eps-beat-revenues-beat"> its most recent </a>quarterly revenue at $954.7 million, well above the $751.49 million consensus estimate.
The company attributed its high revenue in part to restricted supply resulting from bird flu outbreaks. Cal-Maine Foods stock has gained more than 75% over the past six months.&nbsp;
Telsey Advisory Group analyst Sarang Vora initiated coverage this week on Vital Farms, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VITL#NASDAQ">VITL</a>), a smaller producer specializing in pasture-raised eggs. Vora said he sees the company&#8217;s sales growing at an annual growth rate of 19% to 20% and hitting the $1 billion mark in 2027, versus $600 million in 2024. 
This week, Rose Acre Farms, the second-largest egg producer in the U.S., confirmed its chickens had tested positive for bird flu, likely extending the period of high egg prices and shortages. 
Read Next:&nbsp;
<ul>
<li><a href="https://www.benzinga.com/news/earnings/25/01/43320124/microsoft-shares-slide-after-q2-results-cloud-revenue-misses-expectations-details">Microsoft Shares Slide After Q2 Results, Cloud Revenue Misses Expectations: Details</a>&nbsp;</li>
</ul>
Image: Shutterstock

News

Health Care

General

CALM

COST

VITL

Eggs Prices Soar As Bird Flu Spreads: Why Experts Expect Another 45% Increase In 2025

<a href="https://www.benzinga.com/real-estate/24/12/42368125/i-wonder-how-young-people-today-survive-robert-kiyosaki-says-spending-14-on-an-egg-salad-sandwich-was-hard-to-swallow">Robert Kiyosaki</a>, the author of Rich Dad Poor Dad, has never been shy about making bold predictions. On Jan. 26, he took to X to double down on what <a href="https://www.benzinga.com/personal-finance/24/07/40041316/laugh-all-you-want-robert-kiyosaki-rich-dad-poor-dad-warns-millions-of-401-k-s-and-iras-will-be-">he's been warning about for years</a>: a massive stock market crash. This time, though, he's naming a specific date – February 2025 – as the tipping point for what he calls "the biggest stock market crash in history."
In his post, Kiyosaki referenced his 2013 book, Rich Dad's Prophecy, where he claimed this crash was inevitable. But it's not just doom and gloom from him. Kiyosaki argues that market crashes create opportunities for those prepared, saying everything from cars to houses will "go on sale." He wrote, "Good news because in a crash everything goes on sale. Cars and houses on sale now."
Don't Miss:
<ul>
<li>Nancy Pelosi Invested $5 Million In An AI Company Last Year — <a href="https://www.benzinga.com/money/elf-labs-nancy-pelosi">Here's How You Can Invest In Multiple Pre-IPO AI Startups With Just $1,000</a></li>
<li>Deloitte's fastest-growing software company partners with Amazon, Walmart &amp; Target – <a href="https://www.benzinga.com/money/mode-mobile-2">Many are rushing to grab 4,000 of its pre-IPO shares for just $0.26/share!</a></li>
</ul>
Even more interestingly, he predicts that billions will leave traditional investments like stocks and bonds, flowing into assets like Bitcoin, gold and silver. He advises people to "get out of fake and into real," emphasizing that even owning a single Satoshi could be enough to secure wealth in the chaos.
But Kiyosaki isn't alone in predicting trouble.
Goldman Sachs analysts also warn of a significant market correction, estimating a potential 30% drop in 2025. Their concerns stem from high valuations and ongoing economic uncertainty. Economist Harry Dent is on a similar page, pointing to <a href="https://www.benzinga.com/personal-finance/24/11/42236424/1-in-5-dollars-the-government-expends-goes-to-repaying-investors-heres-why-this-spells-trouble-for-trump-and-doge">America's growing private debt</a> as a time bomb waiting to go off. Dent has even said the bubble could burst as early as mid-2025.
Trending: Built on the trusted network of Fortune 500 companies, <a href="https://www.benzinga.com/money/web3-enabler-the-most-boring-blockchain-company-partners-with-salesforce">this blockchain company partners with Salesforce to uproot lengthy and expensive B2B transactions, and you can invest with just $100.</a>
Meanwhile, Jeremy Grantham, a veteran investor known for spotting financial bubbles, is predicting a "cataclysmic decline" in the stock market. He attributes this to overvaluation, demographic shifts like declining population growth, and global challenges such as climate change.
With heavyweights like Kiyosaki, Goldman Sachs, Dent and Grantham all predicting a downturn, the message is clear: prepare now. While the specifics of these warnings differ, they all share a common theme – markets are fragile, and significant challenges are ahead.
For the average investor, this means reassessing your financial strategy. Diversification becomes even more critical in uncertain times. Kiyosaki suggests moving from traditional "fake" assets like stocks and bonds into alternatives like cryptocurrency, gold and silver. While his Bitcoin predictions of "boom, boom, boom" may seem extreme, crypto has historically performed well during periods of economic uncertainty.
See Also: Maker of the $60,000 foldable home has 3 factory buildings, 600+ houses built, and big plans to solve housing —<a href="https://www.benzinga.com/money/boxabl"> you can become an investor for $0.80 per share today.</a>
Experts recommend having a clear plan for market volatility. <a href="https://www.benzinga.com/personal-finance/24/08/40531988/you-dont-need-emergency-savings-says-grant-cardone-claims-that-three-months-of-savings-in-case-o">Building emergency savings</a>, paying down debt, and diversifying your investments are key steps to weather a potential storm.
No one can predict the future with absolute certainty, but financial experts' growing chorus of warnings is hard to ignore. Whether or not February 2025 brings the "biggest crash in history," it's a good time to <a href="https://www.benzinga.com/money/are-you-rich">evaluate your financial health</a> and make adjustments if needed. After all, as Kiyosaki often reminds us, in every crash lies an opportunity – if you're prepared for it.
Read Next:
<ul>
<li>Inspired by Uber and Airbnb &#8211; Deloitte's fastest-growing software company is transforming 7 billion smartphones into income-generating assets &#8211; <a href="https://www.benzinga.com/money/mode-mobile-2">with $1,000 you can invest at just $0.26/share!</a></li>
<li>If there was a new fund backed by Jeff Bezos offering a <a href="https://www.benzinga.com/money/arrived-private-credit-fund">7-9% target yield with monthly dividends would you invest in it</a>?</li>
</ul>

Robert Kiyosaki, 'Rich Dad, Poor Dad,' Warns The Biggest Stock Market Crash Ever Is Coming February – 'Good News Is Everything Goes On Sale'

Outlook
The company anticipates that adjusted earnings per share for the full year 2025 will be in the range of $7.75 to $8.05, which at the mid-point represents EPS growth of 7% excluding the impact of foreign currency translation and a higher tax rate. This range is based on current global economic activity and foreign exchange rates, ongoing soft global industrial production, and mixed demand across the various regions in which we operate. The company expects that annual EPS growth will be weighted toward the second half of 2025 as global industrial demand weakened and the U.S. dollar strengthened in the second half of 2024. Additionally, we expect to realize more than $100 million in annualized share gains in our Industrial Coatings segment beginning in the second half of the year.
Additional information related to 2025 financial projections is posted within the slides and prepared commentary associated with the fourth quarter earnings documents on the Investors section of PPG.com.
The term organic sales as used in this press release is defined as net sales excluding the impact of currency, acquisitions and divestitures.

Guidance

PPG Anticipates Adj EPS For FY25 Will Be In The Range Of $7.75-$8.05 Vs $8.68 Est.

PPG Indus (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PPG#NYSE">PPG</a>) reported quarterly earnings of $1.61 per share which missed the analyst consensus estimate of $1.65 by 2.42 percent. This is a 3.21 percent increase over earnings of $1.56 per share from the same period last year.

Earnings

PPG Indus Q4 Adj EPS $1.61 Misses $1.65 Estimate

Eli Lilly (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LLY#NYSE">LLY</a>) has outperformed the market over the past 20 years by 6.03% on an annualized basis producing an average annual return of 14.45%. Currently, Eli Lilly has a market capitalization of $740.34 billion. 
Buying $100 In LLY: If an investor had bought $100 of LLY stock 20 years ago, it would be worth $1,476.91 today based on a price of $823.23 for LLY at the time of writing.
<h3>Eli Lilly's Performance Over Last 20 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1738280753_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Trading Ideas

$100 Invested In This Stock 20 Years Ago Would Be Worth This Much Today

Wells Fargo analyst Donald Fandetti maintains AGNC Investment (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AGNC#NASDAQ">AGNC</a>) with a Overweight and lowers the price target from $12 to $11.

Price Target

Analyst Ratings

AGNC

Wells Fargo Maintains Overweight on AGNC Investment, Lowers Price Target to $11

Billionaire Jeff Bezos appears to have a major conflict of interest on his hands with a newspaper he owns trying to get records from another<a href="https://www.benzinga.com/news/21/04/20675447/5-things-you-might-not-know-about-jeff-bezos"> company he founded.</a>
What Happened: While he's <a href="https://www.benzinga.com/news/21/07/21849808/jeff-bezos-is-officially-no-longer-the-amazon-ceo">no longer the CEO</a> of Amazon.com Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>), Bezos remains a shareholder and the executive chairman of the company.
This means that a lawsuit filed by Amazon against the Washington Post, which Bezos owns, now has the billionaire on both sides of the legal fight.
The Washington Post is trying to obtain records related to Amazon's Project Kuiper satellite business, <a href="https://www.hollywoodreporter.com/business/business-news/jeff-bezos-amazon-sues-block-records-requests-washington-post-1236121933/">according </a>to The Hollywood Reporter.
Amazon is fighting back and has sued to block the records request as the e-commerce company states releasing the information could be harmful as it contains trade secrets.
The report says items requested by the news outlet include inspection records, investigation notes and complaints related to visits to the company by the Washington Department of Labor and Industries.
Amazon says the records contain proprietary satellite designs and other information that could give competitors "a competitive edge."
Amazon has not sued the newspaper directly, instead filing a lawsuit against a Washington state agency that agreed to disclose the records. The company is not seeking to block the release of all of the requested records, only a small portion that it believes contains trade secrets.
You may not be a billionaire like Jeff Bezos, but you can uncover hidden gems in the stock market using our proprietary data and pattern recognition — <a href="https://www.benzinga.com/trading-ideas/25/01/43201590/benzinga-stock-whisper-index-5-stocks-investors-secretly-monitor-but-dont-talk-about-yet-2">check out five stocks flying under the radar that deserve your attention.</a>
Why It's Important: The news of the battle by The Washington Post against Amazon comes as the newspaper faces public pushback after <a href="https://www.benzinga.com/general/politics/24/10/41557083/jeff-bezos-ends-washington-posts-36-year-tradition-of-endorsements-leaving-staff-roiled">not endorsing a candidate </a>for president for the first time since 1988.
The decision was said to have been made by Bezos, who bought the newspaper in 2013. The move led to the exit of several newspaper workers and saw around 250,000 subscribers cancel their subscriptions as a result.
The battle between The Washington Post and Amazon and the outcome could become a storyline for Bezos and whether or not billionaires should own news outlets.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/general/education/24/09/41107170/jeff-bezos-used-this-method-to-get-true-opinions-from-employees-amazon-founder-says-youre-the-b">Jeff Bezos Used This Method To Get True Opinions From Employees: Amazon Founder Says &#8216;You&#8217;re The Boss&#8217;</a></li>
</ul>
Photos: Shutterstock

SPACE

Media

AMZN

Bezos Vs. Bezos: Amazon Files Lawsuit Related To Washington Post In Major Conflict Of Interest For Billionaire

Wells Fargo analyst Larry Biegelsen maintains NeuroPace (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NPCE#NASDAQ">NPCE</a>) with a Overweight and raises the price target from $13 to $17.

NPCE

Wells Fargo Maintains Overweight on NeuroPace, Raises Price Target to $17

Wells Fargo analyst Ike Boruchow maintains Victoria's Secret (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VSCO#NYSE">VSCO</a>) with a Equal-Weight and lowers the price target from $45 to $40.

VSCO

Wells Fargo Maintains Equal-Weight on Victoria's Secret, Lowers Price Target to $40

Wells Fargo analyst Matthew Akers maintains RTX (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RTX#NYSE">RTX</a>) with a Overweight and raises the price target from $151 to $156.

Wells Fargo Maintains Overweight on RTX, Raises Price Target to $156

Wells Fargo analyst Matthew Akers maintains Lockheed Martin (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LMT#NYSE">LMT</a>) with a Equal-Weight and lowers the price target from $500 to $497.

Wells Fargo Maintains Equal-Weight on Lockheed Martin, Lowers Price Target to $497

Wells Fargo analyst Derek Archila maintains Zentalis Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZNTL#NASDAQ">ZNTL</a>) with a Equal-Weight and lowers the price target from $8 to $6.

ZNTL

Wells Fargo Maintains Equal-Weight on Zentalis Pharma, Lowers Price Target to $6

Wells Fargo analyst Zachary Fadem maintains Brinker International (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EAT#NYSE">EAT</a>) with a Equal-Weight and raises the price target from $145 to $175.

Wells Fargo Maintains Equal-Weight on Brinker International, Raises Price Target to $175

Wells Fargo analyst David Lantz maintains Monro (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MNRO#NASDAQ">MNRO</a>) with a Equal-Weight and lowers the price target from $24 to $20.

MNRO

Wells Fargo Maintains Equal-Weight on Monro, Lowers Price Target to $20

Blackstone (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BX#NYSE">BX</a>) has outperformed the market over the past 15 years by 6.96% on an annualized basis producing an average annual return of 19.23%. Currently, Blackstone has a market capitalization of $135.00 billion. 
Buying $1000 In BX: If an investor had bought $1000 of BX stock 15 years ago, it would be worth $13,976.42 today based on a price of $177.82 for BX at the time of writing.
<h3>Blackstone's Performance Over Last 15 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1738279807_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

If You Invested $1000 In This Stock 15 Years Ago, You Would Have This Much Today

Wells Fargo analyst Ike Boruchow maintains VF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VFC#NYSE">VFC</a>) with a Underweight and raises the price target from $17 to $21.

Wells Fargo Maintains Underweight on VF, Raises Price Target to $21

UBS analyst Alex Kramm maintains Nasdaq (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NDAQ#NASDAQ">NDAQ</a>) with a Neutral and raises the price target from $79 to $89.

NDAQ

UBS Maintains Neutral on Nasdaq, Raises Price Target to $89

UBS analyst Gregg Orrill maintains PG&amp;E (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PCG#NYSE">PCG</a>) with a Buy and lowers the price target from $24 to $22.

UBS Maintains Buy on PG&E, Lowers Price Target to $22

UBS analyst Ashwani Verma maintains Teva Pharmaceutical Indus (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TEVA#NYSE">TEVA</a>) with a Buy and lowers the price target from $30 to $27.

TEVA

UBS Maintains Buy on Teva Pharmaceutical Indus, Lowers Price Target to $27

UBS analyst Timothy Arcuri maintains Western Digital (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WDC#NASDAQ">WDC</a>) with a Neutral and lowers the price target from $78 to $70.

UBS Maintains Neutral on Western Digital, Lowers Price Target to $70

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Bluejay Diagnostics (NASDAQ:<a href="https://investorplace.com/stock-quotes/bjdx-stock-quote/">BJDX</a>) just reported results for the fourth quarter of 2023.<ul><li>Bluejay Diagnostics reported earnings per share of -$1.78. This was below the analyst estimate for EPS of -68 cents.</li><li>The company did not report any revenue for the quarter.</li></ul><div>InvestorPlace Earnings is a project that leverages data from <a href="https://www.tradesmith.com">TradeSmith</a> to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at <a href="mailto:editor@investorplace.com">editor@investorplace.com</a>.</div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT771245">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT771236">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2021/01/one-percenter-issues-urgent-warning/?cid=MKT499868&amp;eid=MKT793997">It doesn&rsquo;t matter if you have $500 or $5 million. Do this now.</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/earning-results/2024/03/bjdx-stock-earnings-bluejay-diagnostics-for-q4-of-2023/">BJDX Stock Earnings: Bluejay Diagnostics Misses EPS for Q4 2023</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

BJDX Stock Earnings: Bluejay Diagnostics Misses EPS for Q4 2023

Bluejay Diagnostics (BJDX) has issued an announcement. Bluejay Diagnostics, Inc. has ended its agreement with DLA, LLC, leading to the departure of...

Bluejay Diagnostics Announces CFO Change and Stockholders' Meeting Date

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
We are starting off Wednesday with a breakdown of the biggest pre-market stock movers traders will want to read about!



Moving shares are earnings reports, a reverse stock split and more.



Let&rsquo;s get into that news below!



<h2>Biggest Pre-Market Stock Movers: 10 Top Gainers</h2>



<ol><li>Chicken Soup for the Soul (NASDAQ:<a href="https://investorplace.com/stock-quotes/csse-stock-quote/">CSSE</a>) stock is rocketing more than 68% alongside heavy pre-market trading.</li>



<li>Zapata Computing (NASDAQ:<a href="https://investorplace.com/stock-quotes/zpta-stock-quote/">ZPTA</a>) shares are soaring over 26% alongside <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=318251841&amp;type=PDF&amp;symbol=ZPTA&amp;cdn=84fce7fb704e6ef8a8fd234dc0d1a286&amp;companyName=Zapata+Computing+Holdings+Inc.&amp;formType=S-1&amp;formDescription=Registration+statement+under+Securities+Act+of+1933&amp;dateFiled=2024-04-24">secondary offering news</a>.</li>



<li>GraniteShares 2x Long TSLA Daily ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLR#NASDAQ">TSLR</a>) stock is surging close to 24% following Tesla&rsquo;s (NASDAQ:<a href="https://investorplace.com/stock-quotes/tsla-stock-quote/">TSLA</a>) <a href="https://www.marketwatch.com/livecoverage/tesla-earnings-ev-elon-musk-q1-stock-cybertruck-robotaxi/">latest earnings report</a>.</li>



<li>T-REX 2X Long Tesla Daily Target ETF (NASDAQ:<a href="https://investorplace.com/stock-quotes/tslt-stock-quote/">TSLT</a>) shares are gaining more than 22% for the same reason. </li>



<li>Direxion Daily TSLA Bull 2X Shares (NASDAQ:<a href="https://investorplace.com/stock-quotes/tsll-stock-quote/">TSLL</a>) stock is rising over 22% alongside TSLA earnings.</li>



<li>XBP Europe (NASDAQ:<a href="https://investorplace.com/stock-quotes/xbp-stock-quote/">XBP</a>) shares are increasing more than 22% without any clear news this morning.</li>



<li>B. Riley Financial (NASDAQ:<a href="https://investorplace.com/stock-quotes/rily-stock-quote/">RILY</a>) stock is climbing over 19% with the release of its <a href="https://www.prnewswire.com/news-releases/b-riley-financial-files-2023-annual-report-on-form-10-k-302125970.html">2023 annual report</a>.</li>



<li>Vertiv (NYSE:<a href="https://investorplace.com/stock-quotes/vrt-stock-quote/">VRT</a>) shares are heading more than 16% higher after <a href="https://www.investors.com/news/vertiv-spikes-on-earnings-ai-stocks-nvidia-super-micro/">releasing its Q1 earnings report</a>.</li>



<li>AudioEye (NASDAQ:<a href="https://investorplace.com/stock-quotes/aeye-stock-quote/">AEYE</a>) stock is getting an over 13% boost with its <a href="https://qz.com/audioeye-q1-earnings-snapshot-1851430210">Q1 earnings release</a>.</li>



<li>WiMi Hologram Cloud (NASDAQ:<a href="https://investorplace.com/stock-quotes/wimi-stock-quote/">WIMI</a>) shares are up more than 13% following a <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=318249494&amp;type=PDF&amp;symbol=WIMI&amp;cdn=21b188804ad8e2afae8ca53a0c6f207e&amp;companyName=WiMi+Hologram+Cloud+Inc.&amp;formType=6-K&amp;formDescription=Report+of+foreign+private+issuer+pursuant+to+Rule+13a-16+or+15d-16+under+the+Securities+Exchange+Act+of+1934&amp;dateFiled=2024-04-23">goodwill impairment assessment</a>.</li>
</ol><h2>10 Top Losers</h2>



<ol><li>Evotec (NASDAQ:<a href="https://investorplace.com/stock-quotes/evo-stock-quote/">EVO</a>) shares are plummeting more than 35% alongside its <a href="https://www.nasdaq.com/press-release/evotec-presents-fiscal-year-2023-results-and-announces-priority-reset-to-focus-on">latest earnings report</a>.</li>



<li>Fabrinet (NYSE:<a href="https://investorplace.com/stock-quotes/fn-stock-quote/">FN</a>) stock is diving over 24% after <a href="https://www.nasdaq.com/press-release/fabrinet-to-announce-third-quarter-fiscal-year-2024-financial-results-on-may-6-2024">announcing its earnings date</a>.</li>



<li>GraniteShares 2x Short TSLA Daily ETF (NASDAQ:<a href="https://investorplace.com/stock-quotes/tsdd-stock-quote/">TSDD</a>) shares are dropping more than 23% after TSLA&rsquo;s earnings report.</li>



<li>T-Rex 2X Inverse Tesla Daily Target ETF (NASDAQ:<a href="https://investorplace.com/stock-quotes/tslz-stock-quote/">TSLZ</a>) stock is falling over 23% for the same reason.</li>



<li>Bluejay Diagnostics (NASDAQ:<a href="https://investorplace.com/stock-quotes/bjdx-stock-quote/">BJDX</a>) shares are sliding 20% without any clear news.</li>



<li>Kiora Pharmaceuticals (NASDAQ:<a href="https://investorplace.com/stock-quotes/kprx-stock-quote/">KPRX</a>) stock is decreasing more than 19% today.</li>



<li>Mawson Infrastructure (NASDAQ:<a href="https://investorplace.com/stock-quotes/migi-stock-quote/">MIGI</a>) shares are slipping nearly 16% on Wednesday morning.</li>



<li>Applied DNA Sciences (NASDAQ:<a href="https://investorplace.com/stock-quotes/apdn-stock-quote/">APDN</a>) stock is dipping over 15% ahead of a <a href="https://www.nasdaq.com/press-release/applied-dna-announces-1-for-20-reverse-stock-split-2024-04-22">reverse stock split tomorrow</a>.</li>



<li>BiomX (NYSEMKT:<a href="https://investorplace.com/stock-quotes/phge-stock-quote/">PHGE</a>) shares are declining more than 14% <a href="https://www.nasdaq.com/press-release/biomx-to-present-data-from-phase-1b-2a-study-of-bx004-for-the-treatment-of-cystic">following a rally yesterday</a>.</li>



<li>Ostin Technology (NASDAQ:<a href="https://investorplace.com/stock-quotes/ost-stock-quote/">OST</a>) stock closes out our pre-market stock movers down over 11%.</li>
</ol>On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the&nbsp;InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT771245">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT771236">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2021/01/one-percenter-issues-urgent-warning/?cid=MKT499868&amp;eid=MKT793997">It doesn&rsquo;t matter if you have $500 or $5 million. Do this now.</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/2024/04/todays-biggest-pre-market-stock-movers-10-top-gainers-and-losers-on-wednesday-april-24th/">Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
We have all of the biggest pre-market stock movers that traders will want to read about on Monday morning!



Moving stocks this morning an investor update, clinical trial news, a private offering and more.



Let&rsquo;s get into that news below!



<h2>Biggest Pre-Market Stock Movers: 10 Top Gainers</h2>



<ol><li>Scinai Immunotherapeutics (NASDAQ:<a href="https://investorplace.com/stock-quotes/scni-stock-quote/">SCNI</a>) stock is rocketing more than 69% alongside heavy pre-market trading.</li>



<li>Schmid Group (NASDAQ:<a href="https://investorplace.com/stock-quotes/shmd-stock-quote/">SHMD</a>) shares are soaring 40% without any clear news this morning.</li>



<li>ENDRA Life Sciences (NASDAQ:<a href="https://investorplace.com/stock-quotes/ndra-stock-quote/">NDRA</a>) stock is surging over 36% alongside an <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=318395592&amp;type=PDF&amp;symbol=NDRA&amp;cdn=4506ae3b1a739822361489bedc53ef84&amp;companyName=ENDRA+Life+Sciences+Inc.&amp;formType=SC+13G&amp;formDescription=Statement+of+acquisition+of+beneficial+ownership+by+individuals&amp;dateFiled=2024-06-14">investor stake update</a>.</li>



<li>Maxeon Solar Technologies (NASDAQ:<a href="https://investorplace.com/stock-quotes/maxn-stock-quote/">MAXN</a>) shares are rising more than 21% with strong early morning trading.</li>



<li>Srivaru (NASDAQ:<a href="https://investorplace.com/stock-quotes/svmh-stock-quote/">SVMH</a>) stock is increasing over 18% as it continues to <a href="https://investorplace.com/2024/06/why-is-srivaru-svmh-stock-up-122-today/">rally on e-bike news</a>.</li>



<li>Nurix Therapeutics (NASDAQ:<a href="https://investorplace.com/stock-quotes/nrix-stock-quote/">NRIX</a>) shares are gaining 17% on <a href="https://www.marketwatch.com/story/nurix-therapeutics-shares-rise-on-positive-leukemia-drug-results-66b9d524?mod=investing">positive drug results</a>.</li>



<li>Icecure Medical (NASDAQ:<a href="https://investorplace.com/stock-quotes/iccm-stock-quote/">ICCM</a>) stock is getting a 14% boost with it still rallying on <a href="https://www.nasdaq.com/press-release/positive-data-icecures-kidney-cancer-clinical-study-presented-interventional">kidney cancer study data</a>.</li>



<li>Kineta (NASDAQ:<a href="https://investorplace.com/stock-quotes/ka-stock-quote/">KA</a>) shares are heading more than 13% higher with heavy trading today.</li>



<li>XTL Biopharmaceuticals (NASDAQ:<a href="https://investorplace.com/stock-quotes/xtlb-stock-quote/">XTLB</a>) stock is jumping over 12% this morning.</li>



<li>Conn&rsquo;s (NASDAQ:<a href="https://investorplace.com/stock-quotes/conn-stock-quote/">CONN</a>) shares are up more than 11% today.</li>
</ol><h2>10 Top Losers</h2>



<ol><li>Kaival Brands Innovations (NASDAQ:<a href="https://investorplace.com/stock-quotes/kavl-stock-quote/">KAVL</a>) stock is plummeting more than 35% after a massive rally on Friday.</li>



<li>Sonim Technologies (NASDAQ:<a href="https://investorplace.com/stock-quotes/sonm-stock-quote/">SONM</a>) shares are diving over 25% this morning.</li>



<li>AMC Networks (NASDAQ:<a href="https://investorplace.com/stock-quotes/amcx-stock-quote/">AMCX</a>) stock is tumbling more than 23% after <a href="https://www.nasdaq.com/press-release/amc-networks-inc-announces-private-offering-125-million-convertible-senior-notes-2024">announcing a private offering</a>.</li>



<li>Bluejay Diagnostics (NASDAQ:<a href="https://investorplace.com/stock-quotes/bjdx-stock-quote/">BJDX</a>) shares are taking an over 17% beating despite a lack of news.</li>



<li>Northann (NYSEMKT:<a href="https://investorplace.com/stock-quotes/ncl-stock-quote/">NCL</a>) stock is falling close to 14% without any news to report.</li>



<li>Zapp Electric Vehicles (NASDAQ:<a href="https://investorplace.com/stock-quotes/zapp-stock-quote/">ZAPP</a>) shares are dropping more than 13% as it <a href="https://investorplace.com/2024/06/why-is-zapp-electric-vehicles-zapp-stock-up-173-today/">comes off a rally last week</a>.</li>



<li>Aptevo Therapeutics (NASDAQ:<a href="https://investorplace.com/stock-quotes/apvo-stock-quote/">APVO</a>) stock is decreasing over 13% on a <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=318396271&amp;type=PDF&amp;symbol=APVO&amp;cdn=21e6c068c48621c307f0f74bc8553007&amp;companyName=Aptevo+Therapeutics+Inc.&amp;formType=S-1&amp;formDescription=Registration+statement+under+Securities+Act+of+1933&amp;dateFiled=2024-06-14">proposed public offering</a>.</li>



<li>Feutune Light Acquisition (NASDAQ:<a href="https://investorplace.com/stock-quotes/flfv-stock-quote/">FLFV</a>) shares are slipping almost 12% on Monday.</li>



<li>Volcon (NASDAQ:<a href="https://investorplace.com/stock-quotes/vlcn-stock-quote/">VLCN</a>) stock is dipping more than 11% on <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=318396398&amp;type=PDF&amp;symbol=VLCN&amp;cdn=980b1d9c3f018f25ac11de4d0e102b66&amp;companyName=Volcon+Inc.&amp;formType=8-K&amp;formDescription=Current+report+pursuant+to+Section+13+or+15%28d%29&amp;dateFiled=2024-06-14">a delisting notice</a>.</li>



<li>Holdco Nuvo (NASDAQ:<a href="https://investorplace.com/stock-quotes/nuvo-stock-quote/">NUVO</a>) shares close out our pre-market stock movers down over 11% today.</li>
</ol>On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the&nbsp;InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT802110">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT766411">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget A.I. THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/2024/06/todays-biggest-pre-market-stock-movers-10-top-gainers-and-losers-on-monday-june-17th/">Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday

Bluejay Diagnostics announces 1-for-8 reverse stock split

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Pre-market stock movers are worth checking out on Thursday as we dig into all of the news moving shares this morning!



Moving stocks are public offering updates, new investments an earnings report and more.



Let&rsquo;s get into that news below!



<h2>Biggest Pre-Market Stock Movers: 10 Top Gainers</h2>



<ol><li>Assure (NASDAQ:<a href="https://investorplace.com/stock-quotes/ionm-stock-quote/">IONM</a>) stock is rocketing more than 128% after <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=318417463&amp;type=PDF&amp;symbol=IONM&amp;cdn=8d8708e472ad2a1117d6e2e1ea234033&amp;companyName=Assure+Holdings+Corp.&amp;formType=RW&amp;formDescription=Registration+Withdrawal+Request&amp;dateFiled=2024-06-26">withdrawing a proposed public offering</a>.</li>



<li>Vigil Neuroscience (NASDAQ:<a href="https://investorplace.com/stock-quotes/vigl-stock-quote/">VIGL</a>) shares are soaring over 40% on a <a href="https://www.globenewswire.com/news-release/2024/06/27/2904902/0/en/Vigil-Neuroscience-Announces-40-Million-Strategic-Investment-from-Sanofi.html">$40 million investment</a>.</li>



<li>CASI Pharmaceuticals (NASDAQ:<a href="https://investorplace.com/stock-quotes/casi-stock-quote/">CASI</a>) stock is surging more than 31% on a <a href="https://www.prnewswire.com/news-releases/casi-pharmaceuticals-announces-15-million-private-placement-financing-by-venrock-healthcare-capital-partners-foresite-capital-panacea-venture-and-dr-wei-wu-he-302183230.html">$15 million private placement</a>.</li>



<li>Entero Therapeutics (NASDAQ:<a href="https://investorplace.com/stock-quotes/ento-stock-quote/">ENTO</a>) shares are gaining over 26% on a <a href="https://www.nasdaq.com/press-release/entero-therapeutics-announces-peer-reviewed-publication-unveiling-novel-algorithm">peer-reviewed publication</a>.</li>



<li>Faraday Future (NASDAQ:<a href="https://investorplace.com/stock-quotes/ffie-stock-quote/">FFIE</a>) stock is increasing more than 24% as it <a href="https://investorplace.com/2024/06/faraday-future-ffie-stock-soars-80-following-rivian-volkswagen-deal/">continues a recent rally</a>.</li>



<li>Incannex Healthcare (NASDAQ:<a href="https://investorplace.com/stock-quotes/ixhl-stock-quote/">IXHL</a>) shares are jumping over 23% despite a lack of news this morning.</li>



<li>Geovax Labs (NASDAQ:<a href="https://investorplace.com/stock-quotes/govx-stock-quote/">GOVX</a>) stock is climbing more than 21% without any clear news this morning.</li>



<li>Fresh Vine Wine (NYSEMKT:<a href="https://investorplace.com/stock-quotes/vine-stock-quote/">VINE</a>) shares are heading close to 17% higher with heavy pre-market trading.</li>



<li>Phunware (NASDAQ:<a href="https://investorplace.com/stock-quotes/phun-stock-quote/">PHUN</a>) stock is getting an over 15% boost without any obvious news to report.</li>



<li>Hyzon Motors (NASDAQ:<a href="https://investorplace.com/stock-quotes/hyzn-stock-quote/">HYZN</a>) shares are up nearly 15% with strong trading this morning.</li>
</ol><h2>10 Top Losers</h2>



<ol><li>Branchout Food (NASDAQ:<a href="https://investorplace.com/stock-quotes/bof-stock-quote/">BOF</a>) stock is plummeting more than 37% after <a href="https://www.nasdaq.com/press-release/branchout-food-prices-14-million-follow-public-offering-2024-06-26">pricing a follow-on offering</a>.</li>



<li>Tonix Pharmaceuticals (NASDAQ:<a href="https://investorplace.com/stock-quotes/tnxp-stock-quote/">TNXP</a>) shares are diving over 28% on a <a href="https://www.stocktitan.net/news/TNXP/tonix-pharmaceuticals-announces-proposed-public-d6yhuinwfxm9.html">proposed public offering</a>.</li>



<li>Bluejay Diagnostics (NASDAQ:<a href="https://investorplace.com/stock-quotes/bjdx-stock-quote/">BJDX</a>) stock is tumbling more than 21% after <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=318418078&amp;type=PDF&amp;symbol=BJDX&amp;cdn=14a15ef82de2ebc313ddbbf7cad3f31c&amp;companyName=Bluejay+Diagnostics+Inc.&amp;formType=EFFECT&amp;formDescription=Notice+of+Effectiveness&amp;dateFiled=2024-06-26">effecting a public offering</a>.</li>



<li>Immutep (NASDAQ:<a href="https://investorplace.com/stock-quotes/immp-stock-quote/">IMMP</a>) shares are taking an over 17% beating without any apparent news today.</li>



<li>VSee Health (NASDAQ:<a href="https://investorplace.com/stock-quotes/vsee-stock-quote/">VSEE</a>) stock is slipping more than 17% <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=318417950&amp;type=PDF&amp;symbol=VSEE&amp;cdn=a8750adb0a7c7d12db86db6bfac8e49b&amp;companyName=VSee+Health+Inc.&amp;formType=4&amp;formDescription=Statement+of+changes+in+beneficial+ownership+of+securities&amp;dateFiled=2024-06-26">alongside recent insider trading</a>.</li>



<li>Swvl (NASDAQ:<a href="https://investorplace.com/stock-quotes/swvl-stock-quote/">SWVL</a>) shares are dropping over 16% on Thursday morning.</li>



<li>Levi Strauss (NYSE:<a href="https://investorplace.com/stock-quotes/levi-stock-quote/">LEVI</a>) stock is decreasing more than 16% with its <a href="https://www.cnbc.com/2024/06/26/levi-levi-earnings-q2-2024.html">Q2 earnings report</a>.</li>



<li>International Paper (NYSE:<a href="https://investorplace.com/stock-quotes/ip-stock-quote/">IP</a>) shares are falling over 15% today.</li>



<li>Recursion Pharmaceuticals (NASDAQ:<a href="https://investorplace.com/stock-quotes/rxrx-stock-quote/">RXRX</a>) stock is slipping more than 14% after <a href="https://www.stocktitan.net/news/RXRX/recursion-announces-pricing-of-200-million-public-offering-of-class-49il22g17787.html">pricing a public offering</a>.</li>



<li>KraneShares California Carbon Allowance Strategy ETF (NYSEARCA:<a href="https://investorplace.com/stock-quotes/kcca-stock-quote/">KCCA</a>) shares close out our pre-market stock movers down over 13%. </li>
</ol>On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the&nbsp;InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT802110">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT766411">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget A.I. THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/2024/06/todays-biggest-pre-market-stock-movers-10-top-gainers-and-losers-on-thursday-june-27th/">Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Bluejay Diagnostics (NASDAQ:<a href="https://investorplace.com/stock-quotes/bjdx-stock-quote/">BJDX</a>) just reported results for the second quarter of 2024.<ul><li>Bluejay Diagnostics reported earnings per share of -$5.12. This was below the analyst estimate for EPS of -72 cents.</li><li>The company did not report any revenue for the quarter.</li></ul><div>InvestorPlace Earnings is a project that leverages data from <a href="https://www.tradesmith.com">TradeSmith</a> to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at <a href="mailto:editor@investorplace.com">editor@investorplace.com</a>.</div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget AI... THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul>The post <a href="https://investorplace.com/earning-results/2024/08/bjdx-stock-earnings-bluejay-diagnostics-for-q2-of-2024/">BJDX Stock Earnings: Bluejay Diagnostics Misses EPS for Q2 2024</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

BJDX Stock Earnings: Bluejay Diagnostics Misses EPS for Q2 2024

Bluejay Diagnostics announces 1 for 50 reverse stock split

Bluejay Diagnostics (BJDX) announced that the company's Board of Directors has approved a reverse stock split of its shares of common stock at a ra...

Bluejay Diagnostics announces 1-for-50 reverse stock split

19:50 EST Bluejay Diagnostics (BJDX) Inc trading halted, news pending Published first on TheFly – the ultimate source for real-time, market-moving ...

Comments

Bluejay Diagnostics

Bluejay Diagnostics (BJDX) Opciones

No option chain data available. Please try again later

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL